Litcius/Paper detail

Cell Therapy for Idiopathic Pulmonary Fibrosis: Rationale and Progress to Date

Paschalis Ntolios, Paschalis Steiropoulos, Georgia Karpathiou, Stavros Anevlavis, Τheodoros Karampitsakos, Evangelos Bouros, Μarios E. Froudarakis, Demosthenes Bouros, Argyrios Tzouvelekis

2020BioDrugs26 citationsDOI

Topics & Concepts

MedicinePulmonary fibrosisIdiopathic pulmonary fibrosisDiseaseMesenchymal stem cellPirfenidoneLungImmunologyFibrosisIntensive care medicinePathologyBioinformaticsInternal medicineBiologyInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseasesMesenchymal stem cell research
Cell Therapy for Idiopathic Pulmonary Fibrosis: Rationale and Progress to Date | Litcius